{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T03:05:46Z","timestamp":1769915146917,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Clinique et Biologique"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.tracli.2020.06.001","type":"journal-article","created":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T16:13:54Z","timestamp":1592064834000},"page":"185-190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Red blood cell alloimmunisation after platelet transfusion (excluding ABO blood group system)"],"prefix":"10.1016","volume":"27","author":[{"given":"P.","family":"Moncharmont","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tracli.2020.06.001_bib0205","first-page":"216","article-title":"A prospective study of the incidence of red cell allo-immunisation following transfusion","volume":"71","author":"Redman","year":"1996","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2020.06.001_bib0210","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/bjh.15182","article-title":"Risk factors for red blood cell alloimmunization in the Recipient Epidemiology and Donor Evaluation Study (REDS-III) database","volume":"181","author":"Karafin","year":"2018","journal-title":"Brit J Haematol"},{"key":"10.1016\/j.tracli.2020.06.001_bib0215","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.tracli.2019.02.003","article-title":"Red blood cell alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease","volume":"26","author":"Balbuena-Merle","year":"2019","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.tracli.2020.06.001_bib0220","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1182\/blood-2018-08-833962","article-title":"Transfusion-related red blood cell alloantibodies: induction and consequences","volume":"133","author":"Tormey","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2020.06.001_bib0225","first-page":"235","article-title":"Examination of human platelets for the ABO, MN, Rh, Tja, Lutheran and Lewis system of antigens by means of mixed erythrocyte-platelet agglutination","volume":"1","author":"Ashhurst","year":"1956","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2020.06.001_bib0230","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/vox.12085","article-title":"Human platelet antigens\u00a0\u2013\u00a02013","volume":"106","author":"Curtis","year":"2014","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2020.06.001_bib0235","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1537-2995.1974.tb04548.x","article-title":"Kidd blood-group antigens of leucocytes and platelets","volume":"14","author":"Marsh","year":"1974","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2020.06.001_bib0240","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1537-2995.1974.tb04561.x","article-title":"Studies of MNSsU antigen activity on leucocytes and platelets","volume":"14","author":"Marsh","year":"1974","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2020.06.001_bib0245","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1537-2995.1984.24384225031.x","article-title":"Erythrocyte antigens on human platelets. Absence of Rh, Duffy, Kell, Kidd, and Lutheran antigens","volume":"24","author":"Dunstan","year":"1984","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2020.06.001_bib0250","first-page":"139","article-title":"Rh-incompatible platelet transfusion therapy in cancer patients. A study of 30 cases","volume":"45","author":"Lichtiger","year":"1983","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2020.06.001_bib0255","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/trf.12341","article-title":"Anti-D alloimmunization after D-incompatible platelet transfusions: a 14-year single-institution retrospective review","volume":"54","author":"O\u2019Brien","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2020.06.001_bib0260","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/trf.12972","article-title":"Prospective surveillance of D-recipients of D+ apheresis platelets: alloimmunization against D is not detected","volume":"55","author":"Weinstein","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2020.06.001_bib0265","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1046\/j.1537-2995.2002.00015.x","article-title":"Absence of D alloimmunization in D- pediatric oncology patients receiving D-incompatible single-donor platelets","volume":"42","author":"Molnar","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2020.06.001_bib0270","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1046\/j.1537-2995.1988.28488265260.x","article-title":"Alloimmunization to D antigen and HLA in D-negative immunosuppressed oncology patients","volume":"28","author":"Baldwin","year":"1988","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2020.06.001_bib0275","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1056\/NEJM197104292841704","article-title":"Rh-incompatible platelet transfusions\u00a0\u2013\u00a0Risks and consequences of sensitizing immunosuppressed patients","volume":"284","author":"Goldfinger","year":"1971","journal-title":"NEJM"},{"key":"10.1016\/j.tracli.2020.06.001_bib0280","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1423-0410.1990.tb00856.x","article-title":"Alloimmunization to RhD by platelet transfusions in autologous bone marrow transplant recipients","volume":"59","author":"McLeod","year":"1990","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2020.06.001_bib0285","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/j.1537-2995.2010.02953.x","article-title":"Platelet transfusions from D+ donors to D- patients: a 10-year follow-up study of 1014 patients","volume":"51","author":"Cid","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2020.06.001_bib0290","first-page":"598","article-title":"Low frequency of anti-D alloimmunization following D+ platelet transfusion: the Anti-D Alloimmunization after D-incompatible Platelet Transfusions (ADAPT) study","volume":"168","author":"Cid","year":"2015","journal-title":"Brit J Med"},{"key":"10.1016\/j.tracli.2020.06.001_bib0295","first-page":"s147","article-title":"Red blood cell alloimmunisation after platelet transfusion: a 5-year study","volume":"12","author":"Moncharmont","year":"2014","journal-title":"Blood Transfus"},{"key":"10.1016\/j.tracli.2020.06.001_bib0300","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000488804","article-title":"Anti-D alloimmunization after RhD-positive platelet transfusion in RhD-negative women under 55 years diagnosed with acute leukemia: results of a retrospective study","volume":"45","author":"Villalba","year":"2018","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.tracli.2020.06.001_bib0305","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000490122","article-title":"Platelet transfusion induces alloimmunization to D and non-D Rhesus antigens","volume":"45","author":"Reckhaus","year":"2018","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.tracli.2020.06.001_bib0310","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/j.1537-2995.2006.00829.x","article-title":"A flow cytometric method for detection and enumeration of low-level, residual red blood cells in platelets and mononuclear cell products","volume":"46","author":"Santana","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2020.06.001_bib0315","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1537-2995.2006.00692.x","article-title":"The how and why of exocytes vesicles","volume":"46","author":"Greenwald","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2020.06.001_bib0320","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.tmrv.2019.02.002","article-title":"Extracellular vesicles in red blood cell concentrates: an overview","volume":"33","author":"Wannez","year":"2019","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tracli.2020.06.001_bib0325","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1046\/j.1537-2995.1987.27187121469.x","article-title":"Immunoreactivity of the Rh0(D) antigen in cytoskeleton-free vesicles","volume":"27","author":"Victoria","year":"1987","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2020.06.001_bib0330","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1046\/j.1537-2995.1992.32993110758.x","article-title":"Expression of blood group antigens on red cell microvesicles","volume":"32","author":"Oreskovic","year":"1992","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2020.06.001_bib0335","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1423-0410.2010.01435.x","article-title":"Non-D Rh antibodies appearing after apheresis platelet transfusion: stimulation by red cells or microparticles","volume":"100","author":"Kitazawa","year":"2011","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2020.06.001_bib0340","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000501106","article-title":"Rhesus D antigenic determinants on residual red blood cells in apheresis and buffy coat platelet concentrates","volume":"47","author":"Thibault","year":"2020","journal-title":"Transfus Med Hemoth"},{"key":"10.1016\/j.tracli.2020.06.001_bib0345","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/bjh.13123","article-title":"Red blood cell alloimmunization is influenced by recipient inflammatory state at time of transfusion in patients with sickle cell disease","volume":"168","author":"Fasano","year":"2015","journal-title":"Brit J Haematol"},{"key":"10.1016\/j.tracli.2020.06.001_bib0350","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/bjh.13781","article-title":"Chronic inflammatory autoimmune disorders are a risk factor for blood cell alloimmunization","volume":"174","author":"Ryder","year":"2016","journal-title":"Brit J Haematol"},{"key":"10.1016\/j.tracli.2020.06.001_bib0355","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/bjh.14307","article-title":"Red cell alloimmunisation in patients with different types of infections","volume":"175","author":"Evers","year":"2016","journal-title":"Brit J Haematol"},{"key":"10.1016\/j.tracli.2020.06.001_bib0360","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1537-2995.1968.tb04891.x","article-title":"Antibody-mediated immune suppression to Rh factor: animal models suggesting mechanism of action","volume":"8","author":"Pollack","year":"1968","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2020.06.001_bib0365","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1136\/bmj.1.5696.593","article-title":"Primary immunization of Rh-negative volunteers","volume":"1","author":"Gunson","year":"1970","journal-title":"Brit M J"},{"key":"10.1016\/j.tracli.2020.06.001_bib0370","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1537-2995.1971.tb04425.x","article-title":"Studies on Rh prophylaxis II. Rh immune prophylaxis after transfusion with Rh-positive blood","volume":"11","author":"Pollack","year":"1971","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2020.06.001_bib0375","first-page":"165","article-title":"Intravenous anti-D gammaglobulin for the prevention of rhesus isoimmunization caused by platelet transfusions in patients with malignant diseases","volume":"62","author":"Heim","year":"1992","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2020.06.001_bib0380","first-page":"243","article-title":"A dose of 100 IU intravenous anti-D gammaglobulin is effective for the prevention of RhD immunization after RhD-incompatible single donor platelet transfusion","volume":"66","author":"Zeiler","year":"1994","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2020.06.001_bib0385","series-title":"Platelets transfusion: products, indications. Recommendations of the French Health High Authority","year":"2015"},{"key":"10.1016\/j.tracli.2020.06.001_bib0390","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1111\/trf.13077","article-title":"Easier said than done: ABO compatibility and D matching in apheresis platelet transfusion","volume":"55","author":"Dunbar","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2020.06.001_bib0395","article-title":"D\u00e9cision du 1er avril 2019 fixant la liste et les caract\u00e9ristiques des produits sanguins labiles","year":"2019","journal-title":"Journal Officiel de la R\u00e9publique fran\u00e7aise"},{"key":"10.1016\/j.tracli.2020.06.001_bib0400","first-page":"27","article-title":"Red blood cell storage lesion: causes and potential clinical consequences","volume":"17","author":"Yoshida","year":"2019","journal-title":"Blood Transfus"}],"container-title":["Transfusion Clinique et Biologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782020300720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782020300720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:38:44Z","timestamp":1761129524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1246782020300720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1246782020300720"],"URL":"https:\/\/doi.org\/10.1016\/j.tracli.2020.06.001","relation":{},"ISSN":["1246-7820"],"issn-type":[{"value":"1246-7820","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Red blood cell alloimmunisation after platelet transfusion (excluding ABO blood group system)","name":"articletitle","label":"Article Title"},{"value":"Transfusion Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tracli.2020.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Soci\u00e9t\u00e9 fran\u00e7aise de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}